Advertisement

Related Videos

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

Varsha Gandhi, PhD, on Ibrutinib

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Ian Tannock, MD, PhD, DSc, on Near-Equivalence: A Better Question Than Non-Inferiority

Advertisement

Advertisement




Aug
11
Today In Oncology
FDA Grants Traditional Approval to Selpercatinib for Locally Advanced or Metastatic RET Fusion–Positive Solid Tumors
Outreach to HCT Recipients, Primary Care Doctors May Reduce Skin Cancer Risk
American College of Surgeons Commission on Cancer Introduces Rural Cancer Program Accreditation
Phase III Trial Supports Intensified Total Neoadjuvant Therapy in High-Risk Rectal Cancer
Teclistamab Improves Progression-Free and Overall Survival in Previously Treated Multiple Myeloma
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo